<DOC>
	<DOCNO>NCT00654992</DOCNO>
	<brief_summary>The purpose study determine whether erythropoietin effective prevent acute kidney dysfunction coronary artery bypass graft surgery .</brief_summary>
	<brief_title>Effect Erythropoietin ( EPO ) Kidney After Cardiac Surgery</brief_title>
	<detailed_description>Acute kidney injury ( AKI ) occur 7 % 40 % patient undergoing cardiac surgery , depend definition AKI use . Even small increment serum creatinine show associated increased mortality cardiac surgery . However , proven intervention prevent AKI cardiac surgery . Erythropoietin ( EPO ) show tissue-protective effect various experimental model . In prospective placebo-controlled randomize trial , evaluate effectiveness EPO prevention AKI coronary artery bypass grafting ( CABG ) .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Patients schedule elective CABG age 18 Under age 18 Emergent CABG Prior exposure nephrotoxic drug Dialysis patient Uncontrolled hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>